What is ATRA (ATRA) stock price today?

ATRA (ATRA) is currently trading at $9.31, up 4.61% today.

What is ATRA P/E ratio?

ATRA's P/E ratio is -7.95. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is ATRA return on equity (ROE)?

ATRA's return on equity (ROE) is 44.67%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is ATRA's market cap?

ATRA has a market capitalization of $83.88M.

NASDAQ · Biotechnology

ATRA (ATRA) Stock

$9.31 +4.61% NASDAQ: ATRA Healthcare

Valuation

Metric	Value
Price	$9.31
Market Cap	$83.88M
P/E Ratio	-7.95
P/B Ratio	-3.81
P/S Ratio	13.64
EPS (TTM)	$0.00
52-Week High	$19.14
52-Week Low	$3.92
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	44.67%
ROA	-79.38%
ROCE	-100.35%
Gross Margin	29.75%
Operating Margin	29.75%
Net Margin	-269.42%
Debt/Equity	-0.27
Current Ratio	0.80

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$20.0M	$64.0M	$9.0M	$129.0M	$121.0M
Operating Profit	$-340.0M	$-281.0M	$-276.0M	$-83.0M	$36.0M
Net Profit	$-340.0M	$-228.0M	$-276.0M	$-85.0M	$33.0M
EPS	$-90.78	$-55.96	$-65.18	$-11.41	$2.57
Op Margin	-1673.8%	-441.3%	-3219.5%	-64.7%	29.7%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$468.0M	$376.0M	$166.0M	$109.0M	$20.0M
Total Liabilities	$189.0M	$250.0M	$265.0M	$206.0M	$59.0M
Cash	$106.0M	$93.0M	$26.0M	$25.0M	$8.0M
Borrowings	$28.0M	$72.0M	$58.0M	$44.0M	$53.0M

Latest News

Biotech Stocks Surge As UniQure 'Nail-Biting Journey' Comes To An End Investor's Business Daily · Jun 17, 2026 Atara Biotherapeutics Announces Changes to Its Board of Directors Business Wire · Jun 12, 2026 ATRA Stock Shoots Up 82% in a Month: Here's What You Should Know Zacks · May 21, 2026 Atara Biotherapeutics: Q1 Earnings Snapshot Associated Press · May 12, 2026 FDA Resubmission Path for Tab-cel Keeps Atara’s (ATRA) Regulatory Timeline Alive InvestorsHub · May 7, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-221.0M	$-270.0M	$-193.0M	$-69.0M	$-51.0M
Investing Cash Flow	$12.0M	$199.0M	$123.0M	$8.0M	$18.0M
Financing Cash Flow	$6.0M	$32.0M	$1.0M	$0	$0
Net Cash Flow	$-94.0M	$-14.0M	$-67.0M	$-1.0M	$-17.0M
Free Cash Flow	$-231.0M	$-275.0M	$-194.0M	$-69.0M	$-51.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.05
EV / EBITDA	-6.68
FCF Yield	-25.91%
Quick Ratio	1.98
Interest Coverage	-5.04
Return 1Y	-7.87%
Return 3Y	-81.33%
Return 5Y	-97.42%

Ownership

Insiders Held16.92%

Institutions Held52.46%

Institutions Float Held63.15%

Institutional Holder	Shares	Report Date
Adage Capital Partners GP L.L.C.	700,000	2026-03-31
Redmile Group, LLC	441,701	2026-03-31
Mackenzie Financial Corporation	313,620	2026-03-31
Vanguard Capital Management LLC	217,862	2026-03-31
Point72 Asset Management, L.P.	194,264	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CLNN	$4.24	-0.93%	-1.31	$54.18M	0.00%
CNTX	$0.36	-7.44%	-6.84	$33.14M	0.00%
COYA	$4.52	-0.88%	-2.62	$106.03M	0.00%
CSBR	$5.08	+1.70%	18.33	$70.58M	0.00%
IFRX	$2.25	+5.40%	-4.16	$330.67M	0.00%

About ATRA

ATRA is led by CEO Anhco Nguyen, employs 153 people, headquartered in US, publicly traded since 2014.

ATRA stock trades at $9.31 with a market capitalization of $83.88M. The stock is valued at a price-to-earnings (P/E) ratio of -7.95, price-to-book of -3.81, price-to-sales of 13.64. Over the past 52 weeks the stock has ranged between $3.92 and $19.14, and currently trades 51.4% below its 52-week high.

On profitability, ATRA generates a return on equity (ROE) of 44.67% — well above the market average, a sign of a high-quality business, return on capital employed of -100.35%, an operating margin of 29.75%, a net profit margin of -269.42%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides